32 | Radioisotopes (Radionuclides)IBA
01/2024
-
03/2006 |
25 | AntigensIBA
01/2024
-
08/2005 |
19 | Monoclonal AntibodiesIBA
04/2020
-
10/2005 |
12 | LigandsIBA
05/2024
-
01/2008 |
12 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2023
-
03/2016 |
12 | Immunoconjugates (Immunoconjugate)IBA
05/2022
-
12/2006 |
9 | Substance PIBA
05/2024
-
05/2016 |
8 | Peptides (Polypeptides)IBA
10/2023
-
01/2008 |
8 | AntibodiesIBA
03/2021
-
05/2006 |
7 | Actinium-225IBA
05/2024
-
01/2016 |
6 | Bismuth-213IBA
03/2024
-
03/2006 |
6 | Trastuzumab (Herceptin)FDA Link
12/2022
-
03/2006 |
5 | Single-Domain AntibodiesIBA
01/2023
-
04/2020 |
4 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
06/2023
-
01/2014 |
4 | Peptide Receptors (Peptide Receptor)IBA
06/2023
-
02/2011 |
4 | ErbB Receptors (EGF Receptor)IBA
12/2022
-
10/2009 |
4 | LipidsIBA
01/2022
-
01/2016 |
4 | DNA (Deoxyribonucleic Acid)IBA
01/2019
-
10/2013 |
4 | Proteins (Proteins, Gene)FDA Link
12/2017
-
06/2007 |
3 | RadiopharmaceuticalsIBA
10/2023
-
05/2016 |
3 | Somatostatin Receptors (Somatostatin Receptor)IBA
01/2023
-
12/2018 |
3 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022
-
08/2006 |
3 | Prostate-Specific Antigen (Semenogelase)IBA
10/2021
-
01/2018 |
3 | Pentetic Acid (DTPA)FDA LinkGeneric
04/2020
-
05/2009 |
3 | Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
03/2020
-
04/2017 |
3 | LuciferasesIBA
01/2015
-
10/2009 |
3 | Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
02/2009
-
01/2005 |
2 | Capsules (Microcapsules)IBA
10/2023
-
09/2013 |
2 | InterferonsIBA
01/2023
-
01/2022 |
2 | CytokinesIBA
01/2023
-
01/2022 |
2 | Lutetium-177IBA
05/2022
-
01/2015 |
2 | Therapeutic UsesIBA
03/2021
-
01/2017 |
2 | Chelating AgentsIBA
04/2020
-
05/2016 |
2 | Peptide FragmentsIBA
01/2018
-
04/2017 |
2 | substance P (5-11)IBA
01/2018
-
04/2017 |
2 | Carcinoembryonic AntigenIBA
01/2017
-
10/2005 |
2 | Liposomes (Liposome)IBA
01/2017
-
01/2014 |
2 | Neoplasm Antigens (Tumor Antigens)IBA
04/2016
-
01/2015 |
2 | (213)Bi-DTPA-F3IBA
12/2012
-
04/2012 |
2 | 3-O-(methylthiomethyl)apiitol tetraacetateIBA
02/2009
-
12/2006 |
2 | Plasminogen Activators (Plasminogen Activator)IBA
02/2009
-
01/2005 |
2 | Urokinase Plasminogen Activator ReceptorsIBA
01/2008
-
01/2005 |
2 | Plasminogen InactivatorsIBA
04/2006
-
01/2005 |
1 | PSMA I&TIBA
01/2024 |
1 | yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
10/2023 |
1 | Hormones (Hormone)IBA
01/2023 |
1 | Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2023 |
1 | Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2023 |
1 | OvalbuminIBA
01/2023 |
1 | ChemokinesIBA
01/2023 |
1 | Carbonic Anhydrase IXIBA
05/2022 |
1 | Extracellular Matrix ProteinsIBA
01/2022 |
1 | ParaproteinsIBA
01/2022 |
1 | TenascinIBA
01/2022 |
1 | Interleukin-2 (IL2)IBA
01/2022 |